Order Article Reprints

Zhu G, Ren D, Lei X, Shi R, Zhu S, Zhou N, Zu L, Mello RAD, Chen J, XU S. Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer. Cancers. 2021; 13(6):1397. https://doi.org/10.3390/cancers13061397

Zhu, Guangsheng, Dian Ren, Xi Lei, Ruifeng Shi, Shuai Zhu, Ning Zhou, Lingling Zu, Ramon Andrade De Mello, Jun Chen, and Song XU. 2021. "Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer" Cancers 13, no. 6: 1397. https://doi.org/10.3390/cancers13061397

Zhu, G., Ren, D., Lei, X., Shi, R., Zhu, S., Zhou, N., Zu, L., Mello, R. A. D., Chen, J., & XU, S. (2021). Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer. Cancers, 13(6), 1397. https://doi.org/10.3390/cancers13061397